Trials are underway on a £3.2 million-funded new vaccine to tackle the presence pneumococcal disease, a leading preventable cause of child deaths. Organised by the Infection Innovation Consortium ...

The recently published Association of the British Pharmaceutical Industry (ABPI) Pharmaceutical Competitiveness Framework claims the UK has lost out in investment in three key are ...

One of the biggest quality checks ever attempted on superconducting materials has been completed by Durham University researchers.

Cambridge university spin-out Xampla has won investment worth millions to enable it to develop plant-based polymers capable of replacing single-use plastics. Emerald Technology Ventures, BGF and ...

Drugs that prevent the body from clearing parts of brain cells damaged by cancer could help slow tumour progression, according to a new study.

A scheme to support Britain’s nuclear industry through the development of sustainable graphite supplies has won more than £13 millions worth ...

Generative AI has enabled the creation of novel antibiotics capable of killing two highly drug resistant infections.

Developments in ultrasound technology have provided a means for tackling difficult pollutants in water, avoiding the addition of chemicals in the process.

Creators of a new technology say it could extend the number of therapies that can be administered via pills rather than injections.

Fluid control specialist Bürkert has become an official Siemens Product Partner for Siemen’s SIMATIC Automation Systems. The new partnership ...